Retraction Note To: Journal of Cancer Research and Clinical Oncology (2021) 147:2309–2322.10.1007/s00432-021-03661-z
The Editor-in-Chief has retracted this article because of significant concerns regarding overlaps in a number of Figures presented in this work, which question the integrity of the data, specifically:
Fig. 2b (VHL, panel i) with Fig. 4c (BRCA 2, neg. stain) of a previously published article (Basu et al. 2020a)
Fig. 2b (HIF1α, panel i) with Fig. 5a (panel i) of an article published during the same time frame (Basu et al. 2020b)
Fig. 2c (HIF1α, panel iii) with Fig. 5a (panel iv) of an article published during the same time frame (Basu et al. 2020b)
Therefore, the Editor-in-Chief has lost confidence in the reliability of the presented work.
Mukta Basu agrees to this retraction. Other authors have not responded to any correspondence from the editor/publisher about this retraction.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- Basu M, Ghosh S, Roychowdhury A et al (2020a) Integrative genomics and pathway analysis identified prevalent FA-BRCA pathway alterations in arsenic-associated urinary bladder carcinoma: chronic arsenic accumulation in cancer tissues hampers the FA-BRCA pathway. Genomics 112(6):5055–5065 [DOI] [PubMed] [Google Scholar]
- Basu M, Chakraborty B, Ghosh S et al (2020b) RETRACTED: divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma. Mutagenesis 35(6):499–508. 10.1093/mutage/geaa031 [DOI] [PubMed] [Google Scholar]